So far, known genetic determinants of HPC are deleterious mutations in pan-cancer DNA repair genes (e.g., BRCA1, BRCA2, ATM, etc.)or in the PCa-specific risk genes, HOXB13 [7,8]. The gene discussed is ATM; the disease is posterior cortical atrophy.